These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 1678605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.
    Chen HX, Bamberger U, Heckel A, Guo X, Cheng YC.
    Cancer Res; 1993 May 01; 53(9):1974-7. PubMed ID: 8097671
    [Abstract] [Full Text] [Related]

  • 3. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
    Shalinsky DR, Andreeff M, Howell SB.
    Cancer Res; 1990 Dec 01; 50(23):7537-43. PubMed ID: 1979245
    [Abstract] [Full Text] [Related]

  • 4. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells.
    Mazzanti R, Croop JM, Gatmaitan Z, Budding M, Steiglitz K, Arceci R, Arias IM.
    Oncol Res; 1992 Dec 01; 4(8-9):359-65. PubMed ID: 1362504
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance by two novel indole derivatives.
    Kadam S, Maus M, Poddig J, Schmidt S, Rasmussen R, Novosad E, Plattner J, McAlpine J.
    Cancer Res; 1992 Sep 01; 52(17):4735-40. PubMed ID: 1355008
    [Abstract] [Full Text] [Related]

  • 6. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T, Lübbert M, Martens C, Bross KJ, Fiebig HH, Mertelsmann R, Herrmann F.
    Cytokines Mol Ther; 1995 Jun 01; 1(2):123-32. PubMed ID: 9384669
    [Abstract] [Full Text] [Related]

  • 7. Dipyridamole enhancement of etoposide sensitivity.
    Howell SB, Hom DK, Sanga R, Vick JS, Chan TC.
    Cancer Res; 1989 Aug 01; 49(15):4147-53. PubMed ID: 2545335
    [Abstract] [Full Text] [Related]

  • 8. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD, Carmeli S, Moore RE, Patterson GM.
    Cancer Res; 1993 Mar 15; 53(6):1343-7. PubMed ID: 8095179
    [Abstract] [Full Text] [Related]

  • 9. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K, Wakusawa S, Nakamura S, Tajima K, Hidaka H.
    Anticancer Res; 1992 Mar 15; 12(3):649-53. PubMed ID: 1622121
    [Abstract] [Full Text] [Related]

  • 10. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B, Prichard RK, Georges E.
    Mol Pharmacol; 1994 Jun 15; 45(6):1145-52. PubMed ID: 7912815
    [Abstract] [Full Text] [Related]

  • 11. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 12. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
    Leveille-Webster CR, Arias IA.
    Clin Cancer Res; 1996 Apr 15; 2(4):695-706. PubMed ID: 9816220
    [Abstract] [Full Text] [Related]

  • 13. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
    Hung WC, Chuang LY.
    Br J Cancer; 1999 May 15; 80(5-6):705-10. PubMed ID: 10360647
    [Abstract] [Full Text] [Related]

  • 14. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 15; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

  • 15. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M, Madafiglio J, Norris MD, Haber M.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):79-85. PubMed ID: 8093660
    [Abstract] [Full Text] [Related]

  • 16. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM, Arnold ST, Felsted RL, Sinha BK.
    Mol Pharmacol; 1990 Jun 15; 37(6):790-6. PubMed ID: 1972771
    [Abstract] [Full Text] [Related]

  • 17. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S, Yoshimura A, Kikuchi H, Sumizawa T, Kuwano M, Tahara Y.
    Mol Pharmacol; 1989 Nov 15; 36(5):730-5. PubMed ID: 2573823
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
    Howell SB, Hom D, Sanga R, Vick JS, Abramson IS.
    Cancer Res; 1989 Jun 15; 49(12):3178-83. PubMed ID: 2720673
    [Abstract] [Full Text] [Related]

  • 19. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
    Jekunen A, Vick J, Sanga R, Chan TC, Howell SB.
    Cancer Res; 1992 Jul 01; 52(13):3566-71. PubMed ID: 1617625
    [Abstract] [Full Text] [Related]

  • 20. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I.
    Cancer Res; 1986 Nov 01; 46(11):5941-6. PubMed ID: 3756931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.